urovestВестник урологииUrology Herald2308-6424Rostov State Medical University10.21886/2308-6424-2024-12-6-83-88urovest-984Research ArticleОБЗОРЫ ПУБЛИКАЦИЙ – ТЕКУЩЕЕ МНЕНИЕCURRENT STATE-OF-THE-ARTФуразидин (Фурамаг®) в лечении острого и рецидивирующего цистита у женщинFurazidine (Furamag®) in the management of acute and recurrent cystitis in womenhttps://orcid.org/0000-0002-6096-5723ПушкарьД. Ю.PushkarD. Yu.

Дмитрий Юрьевич Пушкарь, д-р мед. наук, профессор, акад. РАН

Москва

Dmitriy Yu. Pushkar, Dr.Sc.(Med), Full Prof., Acad.of the RAS

Moscow

pushkardm@mail.ruhttps://orcid.org/0000-0001-8361-585XБерниковА. Н.BernikovA. N.

Александр Николаевич Берников, канд. мед. наук, доцент

Москва

Alexander N. Bernikov, Cand.Sc.(Med), Assoc. Prof. (Docent)

Moscow

bernikov@mac.comhttps://orcid.org/0000-0001-8383-3507РаснерП. И.RasnerP. I.

Павел Ильич Раснер, д-р мед. наук

Москва

Pavel I. Rasner, Dr.Sc. (Med)

Moscow

dr.rasner@gmail.comhttps://orcid.org/0000-0002-6835-0117БормотинА. В.BormotinA. V.

Алексей Владимирович Бормотин, канд. мед. наук, доцент

Москва

Alexey V. Bormotin, Cand.Sc.(Med), Assoc. Prof. (Docent)

Moscow

avbormotin@icloud.comhttps://orcid.org/0009-0008-2961-1688ДьяковВ. В.DyakovV. V.

Владимир Валентинович Дьяков, канд. мед. наук, доцент

Москва

Vladimir V. Dyakov, Cand. Sc. (Med), Assoc. Prof. (Docent)

Moscow

dr.diakov@gmail.comhttps://orcid.org/0000-0003-3127-9270ШведовА. М.ShvedovA. M.

Андрей Михайлович Шведов

Москва

Andrey M. Shvedov

Moscow

dr.shvedov135@mail.ruРоссийский университет медицины; Московский многопрофильный научно-клинический центр им. С. П. БоткинаРоссияRussian University of Medicine (RosUniMed); Botkin Moscow Multidisciplinary Scientific and Clinical CentreRussian FederationМедицинский центр К+31РоссияK+31 Medical CentreRussian Federation2024070120251268388Copyright © Пушкарь Д.Ю., Берников А.Н., Раснер П.И., Бормотин А.В., Дьяков В.В., Шведов А.М., 20252025Пушкарь Д.Ю., Берников А.Н., Раснер П.И., Бормотин А.В., Дьяков В.В., Шведов А.М.Pushkar D.Y., Bernikov A.N., Rasner P.I., Bormotin A.V., Dyakov V.V., Shvedov A.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.urovest.ru/jour/article/view/984

   Цистит является широко распространённым заболеванием, только в России каждый год фиксируют до 36 млн случаев данного заболевания, при этом у 10 % пациентов болезнь переходит в хроническую рецидивирующую форму. Возникновение хронического цистита у женщин напрямую связано с анатомо-топографическими особенностями мочеполовой системы, наличием гинекологических заболеваний и гормональным статусом. Для эффективного лечения острого или хронического цистита проводится комплексная терапия, при этом именно адекватный выбор антибактериальных препаратов является залогом успеха.

   Целью нашей работы было изучение литературных данных по эффективности применения препарата Фурамаг® в комплексном лечении пациенток с острым и хроническим циститом.

   Для этого был проведён поиск статей в научных базах данных PubMed, Medline, minzdrav.gov.ru, elibrary.ru по запросам «инфекция мочевыводящих путей», «острый цистит» «хронический цистит», «фуразидин», «фуразидин калия». По результатам проведённого поиска сделан вывод, что препарат Фурамаг® в течение длительного времени успешно применяется в лечении острого и хронического цистита, демонстрируя высокую эффективность и хорошую переносимость пациентами, что объясняет его повсеместное использование в рутинной клинической практике урологов, гинекологов и терапевтов.

   Cystitis is a common disease worldwide, with up to 36 million cases recorded annually in Russia alone. In 10 % of patients, the condition transforms into a chronic recurrent form. Up to 30 % of visits to outpatient urologists are related to acute or recurrent cystitis. The prevalence of chronic cystitis in women is closely linked to the anatomical and topographical characteristics of the genitourinary system, the presence of gynecological diseases, and hormonal status. Effective treatment for acute or chronic cystitis involves complex therapy, with the key to success lying in the appropriate selection of antibacterial drugs. The current study aimed to analyse the literature data on the effectiveness of Furamag® in the complex treatment of patients with acute and chronic cystitis. To achieve this objective, we conducted a search for articles in scientific databases such as PubMed, Medline, minzdrav.gov.ru, and elibrary.ru using the following keywords: «urinary tract infection», «acute cystitis», «chronic cystitis», «furazidine», «potassium furazidine». Based on the results of our search, we concluded that Furamag® has been successfully used for a long time in the treatment of both acute and chronic cystitis, demonstrating high efficacy and good patient tolerance. This explains its widespread use in routine clinical practice among urologists, gynecologists, and therapists.

фурамагфуразидин калияинфекция мочевыводящих путейострый циститfuramagpotassium furazidineurinary tract infectionacute cystitisИсследование не имело спонсорской поддержкиThe study was not sponsoredReferencesGaitonde S, Malik RD, Zimmern PE. Financial Burden of Recurrent Urinary Tract Infections in Women: A Time-driven Activity-based Cost Analysis. Urology. 2019;128:47-54. DOI: 10.1016/j.urology.2019.01.031Gaitonde S, Malik RD, Zimmern PE. Financial Burden of Recurrent Urinary Tract Infections in Women: A Time-driven Activity-based Cost Analysis. Urology. 2019;128:47-54. DOI: 10.1016/j.urology.2019.01.031Аполихин О.И., Сивков А.В., Москалева Н.Г., Солнцева Т.В., Комарова В.А. Анализ уронефрологической заболеваемости в Российской Федерации, по данным официальной статистики. Экспериментальная и клиническая урология. 2010;(2):4-11. eLIBRARY ID: 17418791; EDN: OREOKZApolihin O.I., Sivkov A.V., Moskaleva N.G., Solntseva T.V., Komarova V.A. Analysis of uronephrological incidence in children in the Russian Federation according to official statistics. Experimental & clinical urology. 2010;(2):4-11. (In Russian). eLIBRARY ID: 17418791; EDN: OREOKZJung C, Brubaker L. The etiology and management of recurrent urinary tract infections in postmenopausal women. Climacteric. 2019;22(3):242-249. DOI: 10.1080/13697137.2018.1551871Jung C, Brubaker L. The etiology and management of recurrent urinary tract infections in postmenopausal women. Climacteric. 2019;22(3):242-249. DOI: 10.1080/13697137.2018.1551871Medina M, Castillo-Pino E. An introduction to the epidemiology and burden of urinary tract infections. Ther Adv Urol. 2019;11:1756287219832172. DOI: 10.1177/1756287219832172Medina M, Castillo-Pino E. An introduction to the epidemiology and burden of urinary tract infections. Ther Adv Urol. 2019;11:1756287219832172. DOI: 10.1177/1756287219832172Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010;7(12):653-660. DOI: 10.1038/nrurol.2010.190Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010;7(12):653-660. DOI: 10.1038/nrurol.2010.190Malik RD, Wu YR, Christie AL, Alhalabi F, Zimmern PE. Impact of Allergy and Resistance on Antibiotic Selection for Recurrent Urinary Tract Infections in Older Women. Urology. 2018;113:26-33. DOI: 10.1016/j.urology.2017.08.070Malik RD, Wu YR, Christie AL, Alhalabi F, Zimmern PE. Impact of Allergy and Resistance on Antibiotic Selection for Recurrent Urinary Tract Infections in Older Women. Urology. 2018;113:26-33. DOI: 10.1016/j.urology.2017.08.070Naber KG, Cho YH, Matsumoto T, Schaeffer AJ. Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis. Int J Antimicrob Agents. 2009;33(2):111-119. DOI: 10.1016/j.ijantimicag.2008.08.011Naber KG, Cho YH, Matsumoto T, Schaeffer AJ. Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis. Int J Antimicrob Agents. 2009;33(2):111-119. DOI: 10.1016/j.ijantimicag.2008.08.011Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am. 2014;28(1):1-13. DOI: 10.1016/j.idc.2013.09.003Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am. 2014;28(1):1-13. DOI: 10.1016/j.idc.2013.09.003EAU Guidelines. Edn. presented at the EAU Annual Congress Paris 2024. EAU Guidelines Office, Arnhem, The Netherlands; 2024. URL: http://uroweb.org/guidelines/compilations-of-all-guidelines/EAU Guidelines. Edn. presented at the EAU Annual Congress Paris 2024. EAU Guidelines Office, Arnhem, The Netherlands; 2024. URL: http://uroweb.org/guidelines/compilations-of-all-guidelines/Палагин И.С., Сухорукова М.В., Дехнич А.В., Эйдельштейн М.В., Перепанова Т.С., Козлов Р.С., исследовательская группа «ДАРМИС-2018». Антибиотикорезистентность возбудителей внебольничных инфекций мочевых путей в России: результаты многоцентрового исследования «ДАРМИС-2018». Клиническая микробиология и антимикробная химиотерапия. 2019;21(2):134-146. DOI: 10.36488/cmac.2019.2.134-146Palagin I.S., Sukhorukova M.V., Dekhnich A.V., Edelstein M.V., Perepanova T.S., Kozlov R.S., “DARMIS-2018” Study Group. Antimicrobial resistance of pathogens causing community-acquired urinary tract infections in Russia: results of the multicenter study “DARMIS-2018”. Clinical Microbiology and Antimicrobial Chemotherapy. 2019;21(2):134-146. (In Russian). DOI: 10.36488/cmac.2019.2.134-146Ahmed AF, Solyman AA, Kamal SM. Potential host-related risk factors for recurrent urinary tract infection in Saudi women of childbearing age. Int Urogynecol J. 2016;27(8):1245-1253. DOI: 10.1007/s00192-016-2965-0Ahmed AF, Solyman AA, Kamal SM. Potential host-related risk factors for recurrent urinary tract infection in Saudi women of childbearing age. Int Urogynecol J. 2016;27(8):1245-1253. DOI: 10.1007/s00192-016-2965-0Ali SB, Perdawood D, Abdulrahman R, Al Farraj DA, Alkubaisi NA. Vitamin D deficiency as a risk factor for urinary tract infection in women at reproductive age. Saudi J Biol Sci. 2020;27(11):2942-2947. DOI: 10.1016/j.sjbs.2020.08.008Ali SB, Perdawood D, Abdulrahman R, Al Farraj DA, Alkubaisi NA. Vitamin D deficiency as a risk factor for urinary tract infection in women at reproductive age. Saudi J Biol Sci. 2020;27(11):2942-2947. DOI: 10.1016/j.sjbs.2020.08.008Alsubaie SS, Barry MA. Current status of long-term antibiotic prophylaxis for urinary tract infections in children: An antibiotic stewardship challenge. Kidney Res Clin Pract. 2019;38(4):441-454. DOI: 10.23876/j.krcp.19.091Alsubaie SS, Barry MA. Current status of long-term antibiotic prophylaxis for urinary tract infections in children: An antibiotic stewardship challenge. Kidney Res Clin Pract. 2019;38(4):441-454. DOI: 10.23876/j.krcp.19.091Alghoraibi H, Asidan A, Aljawaied R, Almukhayzim R, Alsaydan A, Alamer E, Baharoon W, Masuadi E, Al Shukairi A, Layqah L, Baharoon S. Recurrent Urinary Tract Infection in Adult Patients, Risk Factors, and Efficacy of Low Dose Prophylactic Antibiotics Therapy. J Epidemiol Glob Health. 2023;13(2):200-211. DOI: 10.1007/s44197-023-00105-4Alghoraibi H, Asidan A, Aljawaied R, Almukhayzim R, Alsaydan A, Alamer E, Baharoon W, Masuadi E, Al Shukairi A, Layqah L, Baharoon S. Recurrent Urinary Tract Infection in Adult Patients, Risk Factors, and Efficacy of Low Dose Prophylactic Antibiotics Therapy. J Epidemiol Glob Health. 2023;13(2):200-211. DOI: 10.1007/s44197-023-00105-4Bakke A. Clean intermittent catheterization--physical and psychological complications. Scand J Urol Nephrol Suppl. 1993;150:1-69. PMID: 8438132Bakke A. Clean intermittent catheterization--physical and psychological complications. Scand J Urol Nephrol Suppl. 1993;150:1-69. PMID: 8438132Gonzalez Chiappe S, Lasserre A, Chartier Kastler E, Falchi A, Blaizeau F, Blanchon T, Hanslik T, Denys P. Use of clean intermittent self-catheterization in France: A survey of patient and GP perspectives. Neurourol Urodyn. 2016;35(4):528-534. DOI: 10.1002/nau.22752Gonzalez Chiappe S, Lasserre A, Chartier Kastler E, Falchi A, Blaizeau F, Blanchon T, Hanslik T, Denys P. Use of clean intermittent self-catheterization in France: A survey of patient and GP perspectives. Neurourol Urodyn. 2016;35(4):528-534. DOI: 10.1002/nau.22752Duffy LM, Cleary J, Ahern S, Kuskowski MA, West M, Wheeler L, Mortimer JA. Clean intermittent catheterization: safe, cost-effective bladder management for male residents of VA nursing homes. J Am Geriatr Soc. 1995;43(8):865-870. DOI: 10.1111/j.1532-5415.1995.tb05528.xDuffy LM, Cleary J, Ahern S, Kuskowski MA, West M, Wheeler L, Mortimer JA. Clean intermittent catheterization: safe, cost-effective bladder management for male residents of VA nursing homes. J Am Geriatr Soc. 1995;43(8):865-870. DOI: 10.1111/j.1532-5415.1995.tb05528.xBrennand C, von Wilamowitz-Moellendorff A, Dunn S, Wilkinson J, Chadwick T, Ternent L, Oluboyede Y, Wood R, Walton K, Fader M, N’Dow J, Abdel-Fattah M, McClurg D, Little P, Hilton P, Timoney A, Morris N, Thiruchelvam N, Larcombe J, Harrison S, Armstrong H, McColl E, Pickard R. Antibiotic treatment for intermittent bladder catheterisation with once daily prophylaxis (the AnTIC study): Study protocol for a randomised controlled trial. Trials. 2016;17(1):276. DOI: 10.1186/s13063-016-1389-yBrennand C, von Wilamowitz-Moellendorff A, Dunn S, Wilkinson J, Chadwick T, Ternent L, Oluboyede Y, Wood R, Walton K, Fader M, N’Dow J, Abdel-Fattah M, McClurg D, Little P, Hilton P, Timoney A, Morris N, Thiruchelvam N, Larcombe J, Harrison S, Armstrong H, McColl E, Pickard R. Antibiotic treatment for intermittent bladder catheterisation with once daily prophylaxis (the AnTIC study): Study protocol for a randomised controlled trial. Trials. 2016;17(1):276. DOI: 10.1186/s13063-016-1389-yПерепанова Т.С., Синякова Л.А., Локшин К.Л. Цистит у женщин : Клинические рекомендации. М.: Российское общество урологов; 2021. URL: https://legalacts.ru/doc/klinicheskie-rekomendatsii-tsistit-u-zhenshchin-utv-minzdravom-rossii/Perepanova T.S., Sinjakova L.A., Lokshin K.L. Cistit u zhenshhin : Klinicheskie rekomendacii. M.: Rossijskoe obshhestvo urologov; 2021. (In Russian). URL: https://legalacts.ru/doc/klinicheskie-rekomendatsii-tsistit-u-zhenshchin-utv-minzdravom-rossii/Piédrola Angulo G. La adherencia bacteriana en la patogenia de las ITU [Bacterial adherence in pathogenesis of urinary tract infectious]. An R Acad Nac Med (Madr). 2003;120(3):409-419; discussion 419-425. (In Spanish). PMID: 15027698Piédrola Angulo G. La adherencia bacteriana en la patogenia de las ITU [Bacterial adherence in pathogenesis of urinary tract infectious]. An R Acad Nac Med (Madr). 2003;120(3):409-419; discussion 419-425. (In Spanish). PMID: 15027698Chu CM, Lowder JL. Diagnosis and treatment of urinary tract infections across age groups. Am J Obstet Gynecol. 2018;219(1):40-51. DOI: 10.1016/j.ajog.2017.12.231Chu CM, Lowder JL. Diagnosis and treatment of urinary tract infections across age groups. Am J Obstet Gynecol. 2018;219(1):40-51. DOI: 10.1016/j.ajog.2017.12.231Lugtenberg M, Burgers JS, Zegers-van Schaick JM, Westert GP. Guidelines on uncomplicated urinary tract infections are difficult to follow: perceived barriers and suggested interventions. BMC Fam Pract. 2010;11:51. DOI: 10.1186/1471-2296-11-51Lugtenberg M, Burgers JS, Zegers-van Schaick JM, Westert GP. Guidelines on uncomplicated urinary tract infections are difficult to follow: perceived barriers and suggested interventions. BMC Fam Pract. 2010;11:51. DOI: 10.1186/1471-2296-11-51American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 91: Treatment of urinary tract infections in nonpregnant women. Obstet Gynecol. 2008;111(3):785-794. DOI: 10.1097/AOG.0b013e318169f6efAmerican College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 91: Treatment of urinary tract infections in nonpregnant women. Obstet Gynecol. 2008;111(3):785-794. DOI: 10.1097/AOG.0b013e318169f6efKashanian J, Hakimian P, Blute M Jr, Wong J, Khanna H, Wise G, Shabsigh R. Nitrofurantoin: the return of an old friend in the wake of growing resistance. BJU Int. 2008;102(11):1634-1637. DOI: 10.1111/j.1464-410X.2008.07809.xKashanian J, Hakimian P, Blute M Jr, Wong J, Khanna H, Wise G, Shabsigh R. Nitrofurantoin: the return of an old friend in the wake of growing resistance. BJU Int. 2008;102(11):1634-1637. DOI: 10.1111/j.1464-410X.2008.07809.xЯковлев С.В., Логвинов Л.А., Клочков И.А., Поликарпова С.В., Панин А.Г., Ковыршина Л.А., Бойцов А.Г., Бова С.И., Рычова С.Б. Шеремет О.М. Клиническая и бактериологическая эффективность препарата «Фурамаг» у пациентов с острым циститом. Инфекции и антимикробная терапия. 2005;7(4):120-126.Yakovlev S.V., Logvinov L.A., Klochkov I.A., Polikarpova S.V., Panin A.G., Kovyrshina L.A., Boitsov A.G., Bova S.I., Rychova S.B. Sheremet O.M. Klinicheskaya i bakteriologicheskaya ehffektivnost’ preparata «FuramaG» u patsientov s ostrym tsistitom. Infektsii i antimikrobnaya terapiya. 2005;7(4):120-126. (In Russian).Bielec F, Brauncajs M, Pastuszak-Lewandoska D. Nitrofuran Derivatives Cross-Resistance Evidence-Uropathogenic Escherichia coli Nitrofurantoin and Furazidin In Vitro Susceptibility Testing. J Clin Med. 2023;12(16):5166. DOI: 10.3390/jcm12165166Bielec F, Brauncajs M, Pastuszak-Lewandoska D. Nitrofuran Derivatives Cross-Resistance Evidence-Uropathogenic Escherichia coli Nitrofurantoin and Furazidin In Vitro Susceptibility Testing. J Clin Med. 2023;12(16):5166. DOI: 10.3390/jcm12165166Klesiewicz K., Karczewska E., Nowak P., Mrowiec P., Skiba-Kurek I., Bia£ecka J., Majka Z., Berdzik-Kalarus S., Budak A., Zajdel P. Comparative in vitro studies of furazidin and nitrofurantoin activities against common uropathogens including multidrug-resistant strains of E.coli and S.aureus. Acta poloniae pharmaceutica. 2018;75(3):803-812.Klesiewicz K., Karczewska E., Nowak P., Mrowiec P., Skiba-Kurek I., Bia£ecka J., Majka Z., Berdzik-Kalarus S., Budak A., Zajdel P. Comparative in vitro studies of furazidin and nitrofurantoin activities against common uropathogens including multidrug-resistant strains of E.coli and S.aureus. Acta poloniae pharmaceutica. 2018;75(3):803-812.Männistö P, Karttunen P. Pharmacokinetics of furagin, a new nitrofurantoin congener, on human volunteers. Int J Clin Pharmacol Biopharm. 1979;17(6):264-270. PMID: 468451Männistö P, Karttunen P. Pharmacokinetics of furagin, a new nitrofurantoin congener, on human volunteers. Int J Clin Pharmacol Biopharm. 1979;17(6):264-270. PMID: 468451Slapsyte G, Jankauskiene A, Mierauskiene J, Lazutka JR. Cytogenetic analysis of children under long-term antibacterial therapy with nitroheterocyclic compound furagin. Mutat Res. 2001;491(1-2):25-30. DOI: 10.1016/s1383-5718(01)00131-0Slapsyte G, Jankauskiene A, Mierauskiene J, Lazutka JR. Cytogenetic analysis of children under long-term antibacterial therapy with nitroheterocyclic compound furagin. Mutat Res. 2001;491(1-2):25-30. DOI: 10.1016/s1383-5718(01)00131-0Czeizel AE, Rockenbauer M, Sørensen HT, Olsen J. A population-based case-control teratologic study of furazidine, a nitrofuran-derivative treatment during pregnancy. Clin Nephrol. 2000;53(4):257-263. PMID: 10809412Czeizel AE, Rockenbauer M, Sørensen HT, Olsen J. A population-based case-control teratologic study of furazidine, a nitrofuran-derivative treatment during pregnancy. Clin Nephrol. 2000;53(4):257-263. PMID: 10809412Перепанова Т.С., Хазан П.Л. Применение нитрофуранов при инфекции мочевых путей. Эффективная фармакотерапия. 2007;(20):20-30. eLIBRARY ID: 35205094; EDN: XSIEIPPerepanova T.S., Khazan P.L. Primenenie nitrofuranov pri infektsii mochevykh putei. Ehffektivnaya farmakoterapiya. 2007;(20):20-30. (In Russian). eLIBRARY ID: 35205094; EDN: XSIEIPПанин А.Г., Бойцов А.Г., Ковыршина Л.А., Топузов М.Э., Прялухин А.Е. Применение фурамага при лечении острого цистита. Вестник Санкт-Петербургской Государственной Медицинской Академии им. И.И. Мечникова. 2006;7(3):174-176. eLIBRARY ID: 16336555. EDN: NTMVAJPanin A.G., Boitsov A.G., Kovyrshina L.A., Topuzov M.E., Pryalukhin A.E. Furamag use in acute cystitis treatment. Vestnik Sankt-Peterburgskoi Gosudarstvennoi Meditsinskoi Akademii im. I.I. Mechnikova. 2006;7(3):174-176. (In Russian). eLIBRARY ID: 16336555. EDN: NTMVAJКузьменко А.В., Кузьменко В.В., Гяургиев Т.А. Современные тенденции в лечении хронического рецидивирующего бактериального цистита. Урология. 2020;(6):52-57. DOI: 10.18565/urology.2020.6.52-57Kuzmenko A.V., Kuzmenko V.V., Gyaurgiev T.A. Current trends in the treatment of chronic recurrent bacterial cystitis. Urologiia. 2020;(6):52-57. (In Russian). DOI: 10.18565/urology.2020.6.52-57Курносова Н.В., Кузьменко А.В., Кузьменко В.В. Морфометрическая оценка лечения хронического рецидивирующего бактериального цистита у женщин препаратом Фурамаг. Врач-аспирант. 2011;44(1.4):578-583. eLIBRARY ID: 16537033; EDN: NXWWRHKurnosova N.V., Kuzmenko A.V., Kuzmenko V.V. Morphometric estimation of the chronic bacterial cystitis treatment by Furamag. “Postgraduate Doctor” journal. 2011;44(1.4):578-583. (In Russian). eLIBRARY ID: 16537033; EDN: NXWWRHДавыдов А.В., Неймарк А.И. Оценка эффективности применения фитопрепарата Канефрон Н в комплексном лечении пациенток с хроническим циститом. Эффективная фармакотерапия. 2019;15(10): 20-23. DOI: 10.33978/2307-3586-2019-15-10-20-23Davydov A.V., Neymark A.I. Evaluation of the effectiveness of the herbal remedies Canephron N application in the complex treatment of patients with chronic cystitis. Effektivnaya farmakoterapiya. 2019;15(10): 20-23. (In Russian). DOI: 10.33978/2307-3586-2019-15-10-20-23Перепанова Т.С., Хазан П.Л., Волкова Е.М., Эгамбердиев Д.К., Толордава Э.Р., Романова Ю.М. Проблемы лечения рецидивирующей инфекции нижних мочевых путей. Эффективная фармакотерапия. 2011;(43):38-43. eLIBRARY ID: 21705883; EDN: QLMTQWPerepanova T.S., Khazan P.L., Volkova E.M., Egamberdiev D.K., Tolordava E.R., Romanova Yu.M. Problemy lecheniya retsidiviruyushchei infektsii nizhnikh mochevykh putei. Effektivnaya farmakoterapiya. 2011;(43):38-43. (In Russian). eLIBRARY ID: 21705883; EDN: QLMTQW

The authors declare that there are no conflicts of interest present.